Get the app!
Back to Companies

Kailera Therapeutics, Inc.

KLRANasdaqCIK: 0002096997

Recent Form 4 activity at Kailera Therapeutics, Inc. (KLRA) spans 40 filings across 21 insiders (all of them on the buy side). Purchases total $326.8M against $0 in sales — heavily weighted toward buying, for a net purchase of $326.8M. Kaplan Andrew T. is the most active by dollar volume, and the single largest transaction was $135.0M by Kaplan Andrew T.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$360.3M
Purchases
$326.8M
Sales
$0
Unique Insiders
21

Recent Insider Trades

40 loaded
Jul 8KLRA
Kailera Therapeutics, Inc.
Tregoning KathleenInsiderAward$4.1M
Jul 8KLRA
Kailera Therapeutics, Inc.
Tregoning KathleenInsiderOther$0
Jun 11KLRA
Kailera Therapeutics, Inc.
Renaud Ronald C JRInsiderExercise$400.0K
Apr 20KLRA
Kailera Therapeutics, Inc.
Bain Capital Life Sciences Investors, LLCInsiderBuy$25.0M
Apr 22KLRA
Kailera Therapeutics, Inc.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% OwnerConversion$0
Apr 22KLRA
Kailera Therapeutics, Inc.
RTW INVESTMENTS, LPInsiderBuy$8.0M
Apr 20KLRA
Kailera Therapeutics, Inc.
BAIN CAPITAL INVESTORS LLCInsiderBuy$134.4M
Apr 16KLRA
Kailera Therapeutics, Inc.
Clyburn FrankInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
MILLIGAN JOHN FInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Koppel AdamInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Wasserman Scott M.InsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
MACKAY MARTINInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Renaud Ronald C JRInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Akamine ScottInsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Koppel AdamInsiderBuy$25.0M
Apr 20KLRA
Kailera Therapeutics, Inc.
MACKAY MARTINInsiderAward$612.8K
Apr 16KLRA
Kailera Therapeutics, Inc.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% OwnerOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Hite ChristopherInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Coleman Jamie BethInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Bain Capital Life Sciences Investors, LLCInsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Hite ChristopherInsiderAward$612.8K
Apr 16KLRA
Kailera Therapeutics, Inc.
RTW INVESTMENTS, LPInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Stuart Partners, LLC10% OwnerOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
Burgess Paul D.InsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Pagan Douglas W.InsiderAward$3.2M
Apr 20KLRA
Kailera Therapeutics, Inc.
MILLIGAN JOHN FInsiderAward$612.8K
Apr 16KLRA
Kailera Therapeutics, Inc.
Pagan Douglas W.InsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Clyburn FrankInsiderAward$612.8K
Apr 20KLRA
Kailera Therapeutics, Inc.
Burgess Paul D.InsiderAward$3.2M
Apr 20KLRA
Kailera Therapeutics, Inc.
Kaplan Andrew T.InsiderBuy$134.4M
Apr 20KLRA
Kailera Therapeutics, Inc.
Coleman Jamie BethInsiderAward$2.4M
Apr 16KLRA
Kailera Therapeutics, Inc.
Kaplan Andrew T.InsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
BAIN CAPITAL INVESTORS LLCInsiderOther$0
Apr 16KLRA
Kailera Therapeutics, Inc.
CANADA PENSION PLAN INVESTMENT BOARDInsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Akamine ScottInsiderAward$1.9M
Apr 20KLRA
Kailera Therapeutics, Inc.
Renaud Ronald C JRInsiderAward$9.6M
Apr 20KLRA
Kailera Therapeutics, Inc.
Wasserman Scott M.InsiderAward$3.2M
Apr 16KLRA
Kailera Therapeutics, Inc.
Liu YutingInsiderOther$0
Apr 20KLRA
Kailera Therapeutics, Inc.
Cloghessy PaulaInsiderAward$1.9M
Apr 16KLRA
Kailera Therapeutics, Inc.
Cloghessy PaulaInsiderOther$0

40 filings